[Therapy of severe epithelial dysplasia of esophagus. I. Therapeutic effects of Antitumor B III, Antitumor B and tilorone (author's transl)].
D000328:Adult; D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D004365:Drugs, Chinese Herbal; D004935:Esophageal Diseases / Q000188:drug therapy*; D004938:Esophageal Neoplasms / Q000188:drug therapy*; D005260:Female; D005449:Fluorenes / Q000627:therapeutic use*; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D051379:Mice; D008875:Middle Aged; D008517:Phytotherapy; D010936:Plant Extracts / Q000627:therapeutic use*; D010946:Plants, Medicinal; D011230:Precancerous Conditions; D013994:Tilorone / Q000627:therapeutic use*
D000972:Antineoplastic Agents, Phytogenic; C027128:Antitumor B; C027129:Antitumor B III; D004338:Drug Combinations; D004365:Drugs, Chinese Herbal; D005449:Fluorenes; D010936:Plant Extracts; D013994:Tilorone; D005472:Fluorouracil